PureTech Health PLC (PRTC)

Currency in GBP
137.40
-0.60(-0.44%)
Real-time Data·
PRTC Scorecard
Full Analysis
Management has been aggressively buying back shares
PRTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
135.40142.00
52 wk Range
100.40178.00
Key Statistics
Bid/Ask
137.20 / 137.80
Prev. Close
138
Open
142
Day's Range
135.4-142
52 wk Range
100.4-178
Volume
142.45K
Average Volume (3m)
336.71K
1-Year Change
-15.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRTC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
475.53
Upside
+246.10%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

PureTech Health PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

PureTech Health PLC Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The company also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development; oral therapies based on defined bacterial consortia that is in phase 3 clinical stage; and engineering hematopoietic stem cells to enable targeted therapies for patients with blood cancers. Further, it develops voice-based technology platform that detects changes in the sound of voice that are linked with health conditions, including depression, anxiety, and respiratory disease. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Compare PRTC to Peers and Sector

Metrics to compare
PRTC
Peers
Sector
Relationship
P/E Ratio
8.3x−1.7x−0.5x
PEG Ratio
0.04−0.010.00
Price/Book
1.1x3.0x2.6x
Price / LTM Sales
91.5x10.2x3.3x
Upside (Analyst Target)
245.1%296.1%45.1%
Fair Value Upside
Unlock12.9%7.4%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 475.53
(+246.10% Upside)

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
0.39 / --
Revenue / Forecast
4.54M / --
EPS Revisions
Last 90 days

PRTC Income Statement

People Also Watch

399.40
WPP
-0.99%
94.07
NOVN
-0.13%
166.15
CNA
+0.39%
173.50
ASHM
+1.34%
1,007.00
BAB
+0.95%

FAQ

What Stock Exchange Does PureTech Health PLC Trade On?

PureTech Health PLC is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for PureTech Health PLC?

The stock symbol for PureTech Health PLC is "PRTC."

What Is the PureTech Health PLC Market Cap?

As of today, PureTech Health PLC market cap is 331.42M.

What Is PureTech Health PLC's Earnings Per Share (TTM)?

The PureTech Health PLC EPS (TTM) is 0.21.

From a Technical Analysis Perspective, Is PRTC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has PureTech Health PLC Stock Split?

PureTech Health PLC has split 0 times.

How Many Employees Does PureTech Health PLC Have?

PureTech Health PLC has 56 employees.

What is the current trading status of PureTech Health PLC (PRTC)?

As of 04 Aug 2025, PureTech Health PLC (PRTC) is trading at a price of 137.40, with a previous close of 138.00. The stock has fluctuated within a day range of 135.40 to 142.00, while its 52-week range spans from 100.40 to 178.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.